$opt_dummy_attribute

Non Bot Requests

Production - US/PR + non internal users

method

Get Request 

GoodRx Internal User

Not Internal User

Android Gold iCoupon Upsell Eligible Users

Optimizely Edge Route

platform

iOS Users

isDesktop

url_path

Adaptive Datadog RUM Audience

remove address ios

Android Upsell v2

iOS Upsell V2

HCP Opted In

Gold Card Coachmark Flag

Android 7.12.0 and above

X Flags aex-free-home-slice-2

Qualifies for experiment

Android Remove Address requirement eligible users

iOS GHD BODE

userId

Limited Time Promotion Testers

iOS Gold Onboarding

iOS Vaccine Wallet

Android Vaccine Wallet

Android GHD BODE

BDS POS Rebates Android

Rewards Eligible iOS Users

Rewards Eligible Android Users

iOS app rating prompt 

Rx Check-ins Slice 1 iOS

Android PoS Discount limited_time_promotion

pos discount ios

BDS Contactable Persons (xFlag)

environment

Rx Management Team

iOS Gold Annual Plans

[RXMT-39] Enable after iOS 6.0.105 (20220602233750)

Android Gold Annual Plans

Android/CWF Check-ins for All Eligible Users

iOS Rewards Autoenrollment isElegibleForTest

Android Rewards Autoenrollment isElegibleForTest

[RXMT-90] Enable after iOS 7.0.6 (20220722214821)

Production UAT Audience

iOS/CWF Check-ins for All Eligible Users

iOS Pharmacy Mode Activation

Android Smartbin 

[RXMT-173] Enable after iOS 7.0.12 (20220818233547)

[RXMT-221] Enable after iOS 7.0.18 (20221003233358)

AC-PRIV non essential tracking

AndroidSmartBINPreferredPharmacy

iOS Rewards Native

iOS Gold Preferred Pharmacy Audience

Production non internal users

[RXMT-300] Enable after iOS 7.0.26 (20221119002254)

AndroidSmartBIN BottomNavTest 

Android Edit Profile Audience

Android Rewards Release Version

[RXMT-394] Enable after iOS 7.0.33 (20230204004537)

iOS NPC Launch

Android Gold Registration Swap Plan Selection

Android Clear OTP audience 7.0.37 (344)

Android POS discount gate

Android Auth Invalid Token

Gold Badge Test 

iOS 7.8.0 (20230413233651)

Android 7.8.0 (353)

Android Wallet MVP -  Code Complete

[iOS] Wallet

Production - US/PR + non internal users + isEligibleForTest

isEligibleForTest

[Android] Home Tab Redesign Release Version

iOS 7.10.0 (20230427233635)

iOS 7.14.0 Audience

Android 7.11.0 (358)

iOS App Gate exclude 7.12.0 (20230511233635)

Gold Stacked Upsell Test

[Android] RxDetails Page Release Version

[Android] Medicine Cabinet v1 Finalized Release

iOS Gold POS Discount

Android Gold POS MVP

[Android] Medcab Inactive / Active Prescriptions Release

iOS 7.9.1 (20230425002843)

Medicine Cabinet 1.0 Grand Launch

C@E - Non Internal Users + US/PR

iOS 7.20+

Smartbin Gold Card Redesign

iOS 7.3.0 (20230310003544)

Android 7.26.0 and above (374) 

promo_code_ui_update

Web Gold POS Discount

iOS 7.28.1 (20230906205445)

Android 7.31.0 (379)

isEligibleForNotificationCenterMVP

[iOS] 7.31.0

[Android] Gold Rewards Build

iOS 7.33.0 (20231010175727)

iOS 7.36.0 (20231031170017)

Android 7.27.0 (375) and above

GoodSearch Ads Testing

location

grx_internal_user

build

deviceType

hcpExpOptIn

xFlags

isEnrolledInRewards

hasEligibleRewardsClaim

iOS 7.43.0 (20240112003427)

Pharmacy Mode sunsetting audience

iOS Patient Navigator NDS

iOS 7.46.0 (20240205180145)

Android Rewrite Users 7.48.0 (396)

Management with Incretin-based Therapies

Patient telling medical professional his symptoms.
mihailomilovanovic/E+ via Getty Images

herpes: patient explaining symptoms 1350595333

GoodRx

Phone Icon placeholder

Free on the App Store

Free on Google Play

GoodRx health

GoodRx Health Logo

Global: Good Rx Health Logo

Search Bar

GoodRx Health: Header

Health Conditions

GIP Receptor / GLP-1 Receptor Agonists

Zepbound (tirzepatide) promotes <a href='/weight-loss'>weight loss</a>. It may also be used to maintain <a href='/weight-loss'>weight loss</a>. It works by decreasing appetite. Changes to diet and exercise are often combined with this medication. 

Zepbound

Mounjaro (tirzepatide) is covered by some Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. Mounjaro (tirzepatide) is used to improve blood sugar control in adults with <a href='/diabetes-type-2'>type 2 diabetes</a>. Mounjaro is a GIP Receptor/GLP-1 Receptor Agonist, which works by lowering blood sugar levels by releasing more insulin into the bloodstream and making the body more sensitive to insulin. It also decreases the amount of glucose made by the liver and slows down digestion. The most common form of Mounjaro is a carton of 4 pens. It's also available in vials. There are currently no generic alternatives for Mounjaro.

Mounjaro

GLP-1 Agonists

Ozempic (semaglutide) is used to improve blood sugar control in adults with <a href='/diabetes-type-2'>type 2 diabetes</a>. Ozempic is covered by most Medicare and insurance plans, but some pharmacy coupons or cash prices could help offset the cost. Ozempic is a GLP-1 Agonist which works by increasing insulin release and reducing appetite. The most common form of Ozempic is a 2mg prefilled pen. Ozempic is also available as a 3mg prefilled pen. There are currently no generic alternatives for Ozempic. 


Ozempic

Wegovy (semaglutide) is used to help people lose weight and maintain <a href='/weight-loss'>weight loss</a>. Wegovy is not covered by most Medicare and insurance plans, but manufacturer and pharmacy coupons can help offset the cost. Wegovy is a GLP-1 Agnonist, which works by increasing insulin release and reducing appetite. It is used with a reduced calorie diet and exercise. Wegovy is available as cartons of four prefilled pens. There is currently no generic alternative to Wegovy. 

Wegovy

Victoza (<a href='/liraglutide'>liraglutide</a>) is used to treat <a href='/diabetes-type-1'>diabetes type 1</a> and <a href='/diabetes-type-2'>diabetes type 2</a>. Victoza is a GLP-1 agonist, which works by helping the pancreas produce more insulin. The most common form of Victoza is a carton of three 18mg/3ml pens. It is also available as a carton of two 18mg/3ml pens. There are currently no generic alternatives for Victoza. It is covered by most Medicare and insurance plans, but manufacturer and pharmacy coupons can help offset the cost.

Victoza (liraglutide)

Trulicity (dulaglutide) is used as an adjunct to diet and exercise to improve glycemic control in adults with <a href='/diabetes-type-2'>type 2 diabetes</a> mellitus. Trulicity is a GLP-1 Agonist which works by increasing insulin release and reducing appetite. The most common form of Trulicity is a carton of 4 pens. There are currently no generic alternatives for Trulicity. It is covered by some Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower.

Trulicity

Rybelsus (semaglutide) is used to improve blood sugar control in adults with <a href='/diabetes-type-2'>type 2 diabetes</a>. Rybelsus is a GLP-1 Agonist, which works by increasing insulin release and reducing appetite. The most common form of Rybelsus is a 7mg tablet. It's also available in 3mg and 14mg tablets. There are currently no generic alternatives for Rybelsus. It is covered by some Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower.

Rybelsus

Saxenda (<a href='/liraglutide'>liraglutide</a>) promotoes <a href='/weight-loss'>weight loss</a>. It may also be used to maintain <a href='/weight-loss'>weight loss</a>. Saxenda is a is a GLP-1 Agonist which works by increasing insulin release and reducing appetite. Saxenda is only avalible as a carton of five 3ml pens. There are currently no generic alternatives for Saxenda. It is covered by some Medicare and insurance plans, but some pharmacy coupons, manufacturer programs, or cash prices may be lower.

Saxenda

<p>  Bydureon Bcise (<a href='/exenatide'>Exenatide</a>) is used to improve blood sugar control in adults with <a href='/diabetes-type-2'>type 2 diabetes</a>. This medicine may be used with other oral <a href='/diabetes-type-2'>diabetes</a> medicines.  Bydureon Bcise is less popular than other <a href='/diabetes-type-2'>diabetes type 2</a> medications. There are currently no generic alternatives to Bydureon Bcise.  </p>

<p>  GoodRx has partnered with InsideRx and AstraZeneca to reduce the price for this prescription.  Check our savings tips for co-pay cards, assistance programs, and other ways to reduce your cost. Bydureon Bcise is covered by some Medicare and insurance plans.  </p>

Bydureon Bcise

Adlyxin

<a href='/exenatide'>Exenatide</a> (Byetta) is an expensive drug used to improve blood sugar control in adults with <a href='/diabetes-type-2'>type 2 diabetes</a>. This medicine may be used with other oral <a href='/diabetes-type-2'>diabetes</a> medicines. This drug is less popular than comparable drugs. There are currently no generic alternatives for Byetta. It is covered by most Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. 

Byetta (exenatide)

Management with incretin-based therapies helps individuals diagnosed with <a href='/conditions/diabetes-type-2'>type 2 diabetes</a> lower and stabilize their blood sugar levels. This group of medications can also promote <a href='/conditions/weight-loss'>weight loss</a> as an added benefit.

GoodRx Guide

Management with Incretin-based Therapies

Get the facts on Management with Incretin-based Therapies.

Good news for your inbox